Heffernan Michael Thomas 4
4 · Avalo Therapeutics, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Heffernan Michael Thomas
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+29,500→ 29,500 totalExercise: $4.47Exp: 2035-06-17→ Common Stock (29,500 underlying)
Footnotes (1)
- [F1]The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date.